Surface modification of patterned electrospun nanofibrous films via the adhesion of DOPA-bFGF and DOPA-ponericin G1 for skin wound healing
Authors:
- Jing ZhanJZJing Zhan
- Hong XuHXHong Xu
- Yinghui ZhongYZYinghui Zhong
- Qianqian WuQWQianqian Wu
- Zhenning LiuZLZhenning Liu
Open Access
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Materials & Design
- Vol. 188
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology of Jilin Province
This publication has 38 references indexed in Scilit:
- bFGF-grafted electrospun fibrous scaffolds via poly(dopamine) for skin wound healingJournal of Materials Chemistry B, 2014
- Scaffolds for bone tissue engineering fabricated from two different materials by the rapid prototyping technique: PCL versus PLGAJournal of Materials Science: Materials in Medicine, 2012
- Immobilizing natural macromolecule on PLGA electrospun nanofiber with surface entrapment and entrapment-graft techniquesColloids and Surfaces B: Biointerfaces, 2012
- Evaluation of a novel collagen-gelatin scaffold for achieving the sustained release of basic fibroblast growth factor in a diabetic mouse modelJournal of Tissue Engineering and Regenerative Medicine, 2012
- Preparation, characterization and in vitro testing of poly(lactic-co-glycolic) acid/barium titanate nanoparticle composites for enhanced cellular proliferationBiomedical Microdevices, 2010
- Controlling the release of peptide antimicrobial agents from surfacesBiomaterials, 2010
- Electrospun nanofiber meshes with tailored architectures and patterns as potential tissue-engineering scaffoldsBiofabrication, 2009
- The Effects of Local bFGF Release and Uniaxial Strain on Cellular Adaptation and Gene Expression in a 3D Environment: Implications for Ligament Tissue EngineeringTissue Engineering, 2007
- Vascularization and cellularization of collagen scaffolds incorporated with two different collagen‐targeting human basic fibroblast growth factorsJournal of Biomedical Materials Research Part A, 2007
- Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein‐2 with a collagen binding domain derived from von Willebrand factor propolypeptideJournal of Biomedical Materials Research Part A, 2006